side effects of glp 1 oral solution Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus Understanding GLP-1 side effects

At week 72, the clinical data showed that 36.8% of patients receiving semaglutide achieved fibrosis improvement without worsening of NASH and 62.9% achieved NASH resolution without worsening of fibrosis, compared with 22.4% and 34.3%, respectively, in the placebo group (Sanyal et al., 2025)

There are currently three drugs available in the U.S

doi: 10.3389/fpsyt.2022.1002828 Received 25 July 2022 Accepted 10 October 2022 Published 15 November 2022 Volume 13 - 2022 Edited by Bharathi Gadad, Texas Tech University Health Sciences Center El Paso, United States Reviewed by Federica Ferrari, University of Pavia, Italy

Learn More Mood Supports brain health and may help regulate mood